A new multicenter, single-arm, open-label study is the first to exclusively assess bleeding complications in patients undergoing high-risk percutaneous coronary interventions (PCI) with Impella with independent adjudication via a clinical events adjudication committee and will gather meaningful real-world data based on contemporary practice.
TikTok Reveals Consumers Want Engaging Healthcare Content
John Vivoda, Senior Director of Patient Strategy at Wolters Kluwer Health, Technology has drastically changed the way we consume information in our daily lives. That
June 20, 2023